The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
Hypoxia: Overview on Hypoxia-Mediated Mechanisms with a Focus on the Role of HIF Genes
Open accessAbstract
Hypoxia represents a frequent player in a number of malignancies, contributing to the development of the neoplastic disease. This review will discuss the means by which hypoxia powers the mechanisms behind cancer progression, with a majority of examples from lung cancer, the leading malignancy in terms of incidence and mortality rates (the frequent reference toward lung cancer is also for simplification purposes and follow up of the global mechanism in the context of a disease). The effects induced by low oxygen levels are orchestrated by hypoxia-inducible factors (HIFs) which regulate the expression of numerous genes involved in cancer progression. Hypoxia induces epithelial-to-mesenchymal transition (EMT) and metastasis through a complex machinery, by mediating various pathways such as TGF-β, PI3k/Akt, Wnt, and Jagged/Notch. Concomitantly, hypoxic environment has a vast implication in angiogenesis by stimulating vessel growth through the HIF-1α/VEGF axis. Low levels of oxygen can also promote the process through several other secondary factors, including ANGPT2, FGF, and HGF. Metabolic adaptations caused by hypoxia include the Warburg effect—a metabolic switch to glycolysis—and GLUT1 overexpression. The switch is achieved by directly increasing the expression of numerous glycolytic enzymes that are isoforms of those found in non-malignant cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Molecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717 · cited 2×
“However, none of these small molecules were designed for specific targeting of HIF-1α, fact that hampers the translational switch toward the patients due to difficulties in controlling the level of action and selection of the targeted cohort [137].”
BackgroundOverview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
O'Brien, J., Hayder, H., Zayed, Y., & Peng, C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00402 · Cited by 5,287
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
The Warburg Effect: How Does it Benefit Cancer Cells?
Liberti, M. V., & Locasale, J. W. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.12.001 · Cited by 5,150 · cited 2×
“This switch to glycolysis in tumor cells is present even in aerobic conditions and is called the Warburg effect [8].”
BackgroundTargeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981 · cited 1×
“HIF-1, the hypoxic master regulator, binds to the HRE in the promoter region of the key driving entity in angiogenesis—VEGF [84].”
BackgroundKim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis
Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S., Sato, T. N., & Yancopoulos, G. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81813-9 · Cited by 2,847
Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1
Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J., Tepper, O. M., Bastidas, N., Kleinman, M. E., Capla, J. M., Galiano, R. D., Levine, J. P., & Gurtner, G. C. (2004) · Nature Medicine · doi:10.1038/nm1075 · Cited by 2,600
The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy
Muz, B., de la Puente, P., Azab, F., & Azab, A. K. (2015) · Hypoxia · doi:10.2147/hp.s93413 · Cited by 2,066 · cited 1×
“Intuitively, oxygen levels in tumors depend on several factors such as tumor size, stage, and the heterogeneity of the tumor [5].”
BackgroundNon-small cell lung cancer: current treatment and future advances
Zappa, C., & Mousa, S. A. (2016) · Translational Lung Cancer Research · doi:10.21037/tlcr.2016.06.07 · Cited by 1,944
HIF-1α pathway: role, regulation and intervention for cancer therapy
Masoud, G. N., & Li, W. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.05.007 · Cited by 1,871
Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
Weinberg, F., Hamanaka, R., Wheaton, W. W., Weinberg, S., Joseph, J., Lopez, M., Kalyanaraman, B., Mutlu, G. M., Budinger, G. R. S., & Chandel, N. S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003428107 · Cited by 1,742 · cited 2×
“KRAS, a well-known mutated oncogene in lung cancer is an inducer of aerobic glycolysis [120].”
BackgroundHIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression
Keith, B., Johnson, R. S., & Simon, M. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3183 · Cited by 1,693 · cited 9×
“HIF-1α and HIF-2α have different expression profiles and different targets.”
BackgroundInfluentialJoukov, V., Pajusola, K., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., Saksela, O., Kalkkinen, N., & Alitalo, K. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00359.x · Cited by 1,672
General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia.
Wang, G. L., & Semenza, G. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.9.4304 · Cited by 1,468
Achen, M. G., Jeltsch, M., Kukk, E., Mäkinen, T., Vitali, A., Wilks, A. F., Alitalo, K., & Stacker, S. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.548 · Cited by 1,205
Hypoxia-Induced Angiogenesis: Good and Evil
Krock, B. L., Skuli, N., & Simon, M. C. (2011) · Genes & Cancer · doi:10.1177/1947601911423654 · Cited by 1,180
Weidemann, A., & Johnson, R. S. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.12 · Cited by 941
Fasanaro, P., D'Alessandra, Y., Di Stefano, V., Melchionna, R., Romani, S., Pompilio, G., Capogrossi, M. C., & Martelli, F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800731200 · Cited by 912
Ullah, M. S., Davies, A. J., & Halestrap, A. P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511397200 · Cited by 890
Notch signaling mediates hypoxia-induced tumor cell migration and invasion
Sahlgren, C., Gustafsson, M. V., Jin, S., Poellinger, L., & Lendahl, U. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802047105 · Cited by 823 · cited 9×
“Firstly, the duo interacts with SNAIL1 in order to suppress E-cadherin and occludin gene expression [55].”
BackgroundInfluentialLymphangiogenesis and lymphatic vessel remodelling in cancer
Stacker, S. A., Williams, S. P., Karnezis, T., Shayan, R., Fox, S. B., & Achen, M. G. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3677 · Cited by 807
Schoppmann, S. F., Birner, P., Stöckl, J., Kalt, R., Ullrich, R., Caucig, C., Kriehuber, E., Nagy, K., Alitalo, K., & Kerjaschki, D. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64255-1 · Cited by 794
Wheelock, M. J., Shintani, Y., Maeda, M., Fukumoto, Y., & Johnson, K. R. (2008) · Journal of Cell Science · doi:10.1242/jcs.000455 · Cited by 767
Widespread, hypoxia‐inducible expression of HIF‐2α in distinct cell populations of different organs
Wiesener, M. S., Jürgensen, J. S., Rosenberger, C., Scholze, C., Hörstrup, J. H., Warnecke, C., Mandriota, S., Bechmann, I., Frei, U. A., Pugh, C. W., et al. (2003) · The FASEB Journal · doi:10.1096/fj.02-0445fje · Cited by 740
Hypoxia and Metabolic Adaptation of Cancer Cells
Eales, K. L., Hollinshead, K. E. R., & Tennant, D. A. (2016) · Oncogenesis · doi:10.1038/oncsis.2015.50 · Cited by 724 · cited 1×
“These heterodimers consist of an oxygen-sensible α-subunit and a stable β-subunit [11].”
BackgroundTumour suppression by the human von Hippel-Lindau gene product
Iliopoulos, O., Kibel, A., Gray, S., & Kaelin, W. G. (1995) · Nature Medicine · doi:10.1038/nm0895-822 · Cited by 703
Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis
Jolly, M. K. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00155 · Cited by 693
Kukk, E., Lymboussaki, A., Taira, S., Kaipainen, A., Jeltsch, M., Joukov, V., & Alitalo, K. (1996) · Development · doi:10.1242/dev.122.12.3829 · Cited by 690
Vincent, T., Neve, E. P. A., Johnson, J. R., Kukalev, A., Rojo, F., Albanell, J., Pietras, K., Virtanen, I., Philipson, L., Leopold, P. L., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1905 · Cited by 650
Kelly, B. D., Hackett, S. F., Hirota, K., Oshima, Y., Cai, Z., Berg-Dixon, S., Rowan, A., Yan, Z., Campochiaro, P. A., & Semenza, G. L. (2003) · Circulation Research · doi:10.1161/01.res.0000102937.50486.1b · Cited by 611
Zimna, A., & Kurpisz, M. (2015) · BioMed Research International · doi:10.1155/2015/549412 · Cited by 604 · cited 1×
“HIF-1α translocate into the nucleus and binds its heterodimer counterpart, HIF-1β, with consecutive generation of active HIF-1 which is ready to bind to hypoxia-responsive elements (HREs) and regulate the gene expression of various targets [16].”
BackgroundHsu, Y.-L., Hung, J.-Y., Chang, W.-A., Lin, Y.-S., Pan, Y.-C., Tsai, P.-H., Wu, C.-Y., & Kuo, P.-L. (2017) · Oncogene · doi:10.1038/onc.2017.105 · Cited by 597
A Self-Enabling TGFβ Response Coupled to Stress Signaling
Kang, Y., Chen, C.-R., & Massagué, J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00109-6 · Cited by 550
Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling
Rey, S., & Semenza, G. L. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq045 · Cited by 540
Tang, N., Wang, L., Esko, J., Giordano, F. J., Huang, Y., Gerber, H.-P., Ferrara, N., & Johnson, R. S. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.026 · Cited by 540
Hypoxia-Modified Cancer Cell Metabolism
Al Tameemi, W., Dale, T. P., Al-Jumaily, R. M. K., & Forsyth, N. R. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00004 · Cited by 503
Sher, T., Dy, G. K., & Adjei, A. A. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.3.355 · Cited by 498
Tumor Budding: The Name is EMT. Partial EMT.
Grigore, A., Jolly, M., Jia, D., Farach-Carson, M., & Levine, H. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5050051 · Cited by 496
Notch signaling induces cell cycle arrest in small cell lung cancer cells.
Sriuranpong, V., Borges, M. W., Ravi, R. K., Arnold, D. R., Nelkin, B. D., Baylin, S. B., & Ball, D. W. (2001) · PubMed · Cited by 477
Acute postnatal ablation of Hif-2 α results in anemia
Gruber, M., Hu, C.-J., Johnson, R. S., Brown, E. J., Keith, B., & Simon, M. C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608382104 · Cited by 457 · cited 1×
“The target genes control multiple functions such as angiogenesis (by both HIF-1 and HIF-2), erythropoiesis (solely by HIF-2) [17], cell growth, proliferation, metastasis via EMT, and also function as adaptive switches in metabolism.”
Background(2002) · PubMed · Cited by 457
Koong, A. C., Chen, E. Y., & Giaccia, A. J. (1994) · PubMed · Cited by 445
Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy
Meijer, T. W. H., Kaanders, J. H. A. M., Span, P. N., & Bussink, J. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0858 · Cited by 433
Marin-Hernandez, A., Gallardo-Perez, J., Ralph, S., Rodriguez-Enriquez, S., & Moreno-Sanchez, R. (2009) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955709788922610 · Cited by 433
He, Y., Rajantie, I., Pajusola, K., Jeltsch, M., Holopainen, T., Yla-Herttuala, S., Harding, T., Jooss, K., Takahashi, T., & Alitalo, K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4576 · Cited by 410
Glucose transporters in cancer metabolism
Adekola, K., Rosen, S. T., & Shanmugam, M. (2012) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328356da72 · Cited by 382
Lecharpentier, A., Vielh, P., Perez-Moreno, P., Planchard, D., Soria, J. C., & Farace, F. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.405 · Cited by 367
The hypoxia-inducible factor-1α is a negative factor for tumor therapy
Unruh, A., Ressel, A., Mohamed, H. G., Johnson, R. S., Nadrowitz, R., Richter, E., Katschinski, D. M., & Wenger, R. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206385 · Cited by 334
McMahon, S., Charbonneau, M., Grandmont, S., Richard, D. E., & Dubois, C. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604507200 · Cited by 330
Signal Transduction Pathways of EMT Induced by TGF-β, SHH, and WNT and Their Crosstalks
Zhang, J., Tian, X.-J., & Xing, J. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5040041 · Cited by 325
Identification of Hypoxia-Inducible Factor-1α as a Novel Target for miR-17-92 MicroRNA Cluster
Taguchi, A., Yanagisawa, K., Tanaka, M., Cao, K., Matsuyama, Y., Goto, H., & Takahashi, T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6460 · Cited by 299
miRNAs regulate the HIF switch during hypoxia: a novel therapeutic target
Serocki, M., Bartoszewska, S., Janaszak-Jasiecka, A., Ochocka, R. J., Collawn, J. F., & Bartoszewski, R. (2018) · Angiogenesis · doi:10.1007/s10456-018-9600-2 · Cited by 288
Skuli, N., Liu, L., Runge, A., Wang, T., Yuan, L., Patel, S., Iruela-Arispe, L., Simon, M. C., & Keith, B. (2009) · Blood · doi:10.1182/blood-2008-12-193581 · Cited by 255
Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo
Björndahl, M., Cao, R., Nissen, L. J., Clasper, S., Johnson, L. A., Xue, Y., Zhou, Z., Jackson, D., Jon Hansen, A., & Cao, Y. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507865102 · Cited by 249
Hypoxia-Inducible Factors and Cancer
Jun, J. C., Rathore, A., Younas, H., Gilkes, D., & Polotsky, V. Y. (2017) · Current Sleep Medicine Reports · doi:10.1007/s40675-017-0062-7 · Cited by 248
Vascular Endothelial Growth Factor Receptor 3 Is Involved in Tumor Angiogenesis and Growth
Laakkonen, P., Waltari, M., Holopainen, T., Takahashi, T., Pytowski, B., Steiner, P., Hicklin, D., Persaud, K., Tonra, J. R., Witte, L., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3567 · Cited by 241
Overview upon miR-21 in lung cancer: focus on NSCLC
Bica-Pop, C., Cojocneanu-Petric, R., Magdo, L., Raduly, L., Gulei, D., & Berindan-Neagoe, I. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2877-x · Cited by 236
Self-citationMechanism of Hypoxia-Induced NF-κB
Culver, C., Sundqvist, A., Mudie, S., Melvin, A., Xirodimas, D., & Rocha, S. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00409-10 · Cited by 223
Simon, M., Tournaire, R., & Pouyssegur, J. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21558 · Cited by 219
Hoot, K. E., Lighthall, J., Han, G., Lu, S.-L., Li, A., Ju, W., Kulesz-Martin, M., Bottinger, E., & Wang, X.-J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33713 · Cited by 209
Hsu, Y.-L., Hung, J.-Y., Chang, W.-A., Jian, S.-F., Lin, Y.-S., Pan, Y.-C., Wu, C.-Y., & Kuo, P.-L. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2017.11.016 · Cited by 207
Schliekelman, M. J., Taguchi, A., Zhu, J., Dai, X., Rodriguez, J., Celiktas, M., Zhang, Q., Chin, A., Wong, C.-H., Wang, H., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2535 · Cited by 205
Shimoda, L. A., Fallon, M., Pisarcik, S., Wang, J., & Semenza, G. L. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00528.2005 · Cited by 202
MicroRNA-519c Suppresses Hypoxia-Inducible Factor-1α Expression and Tumor Angiogenesis
Cha, S.-T., Chen, P.-S., Johansson, G., Chu, C.-Y., Wang, M.-Y., Jeng, Y.-M., Yu, S.-L., Chen, J.-S., Chang, K.-J., Jee, S.-H., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2448 · Cited by 202
NF-κB Signaling: A Tale of Two Pathways in Skeletal Myogenesis
Bakkar, N., & Guttridge, D. C. (2010) · Physiological Reviews · doi:10.1152/physrev.00040.2009 · Cited by 200
Hassan, K. A., Wang, L., Korkaya, H., Chen, G., Maillard, I., Beer, D. G., Kalemkerian, G. P., & Wicha, M. S. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0370 · Cited by 199
D’Ignazio, L., & Rocha, S. (2016) · Cells · doi:10.3390/cells5010010 · Cited by 188
Epithelial mesenchymal transition and lung cancer.
Xiao, D., & He, J. (2010) · PubMed · doi:10.3978/j.issn.2072-1439.2010.02.03.7 · Cited by 185
Liu, X., Yao, M., Li, N., Wang, C., Zheng, Y., & Cao, X. (2008) · Blood · doi:10.1182/blood-2008-03-144022 · Cited by 180
Hypoxia-responsive miRNAs target argonaute 1 to promote angiogenesis
Chen, Z., Lai, T.-C., Jan, Y.-H., Lin, F.-M., Wang, W.-C., Xiao, H., Wang, Y.-T., Sun, W., Cui, X., Li, Y.-S., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65344 · Cited by 179
Role of lymphangiogenic factors in tumor metastasis
He, Y., Karpanen, T., & Alitalo, K. (2004) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2003.07.003 · Cited by 179
Vascular Endothelial Growth Factor-A Promotes Peritumoral Lymphangiogenesis and Lymphatic Metastasis
Björndahl, M. A., Cao, R., Burton, J. B., Brakenhielm, E., Religa, P., Galter, D., Wu, L., & Cao, Y. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2345 · Cited by 178
Morfoisse, F., Kuchnio, A., Frainay, C., Gomez‐Brouchet, A., Delisle, M., Marzi, S., Helfer, A., Hantelys, F., Pujol, F., Guillermet‐Guibert, J., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2013.12.011 · Cited by 169
SOX9 drives WNT pathway activation in prostate cancer
Ma, F., Ye, H., He, H. H., Gerrin, S. J., Chen, S., Tanenbaum, B. A., Cai, C., Sowalsky, A. G., He, L., Wang, H., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci78815 · Cited by 169
The TWIST1 oncogene is a direct target of hypoxia-inducible factor-2α
Gort, E. H., van Haaften, G. W., Verlaan-Klink, I., Groot, A. J., Plasterk, R. H. A., Shvarts, A., Suijkerbuijk, K. P. M., van Laar, T., van der Wall, E., Raman, V., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210795 · Cited by 157
Human cancers converge at the HIF-2α oncogenic axis
Franovic, A., Holterman, C. E., Payette, J., & Lee, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906432106 · Cited by 154
The Function of Non-Coding RNAs in Lung Cancer Tumorigenesis
Braicu, C., Zimța, A., Haranguș, A., Iurca, I., Irimie, A., Coza, O. F., & Berindan‐Neagoe, I. (2019) · Cancers · doi:10.3390/cancers11050605 · Cited by 153
Self-citationWang, J., Tian, L., Khan, M. N., Zhang, L., Chen, Q., Zhao, Y., Yan, Q., Fu, L., & Liu, J. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.11.037 · Cited by 151
Dønnem, T., Andersen, S., Al-Shibli, K. I., Al‐Saad, S., Busund, L., & Bremnes, R. M. (2010) · Cancer · doi:10.1002/cncr.25551 · Cited by 140
SOX9 Elevation Acts with Canonical WNT Signaling to Drive Gastric Cancer Progression
Santos, J. C., Carrasco‐García, E., García-Puga, M., Aldaz, P., Montes, M., Fernández‐Reyes, M., de Oliveira, C. C., Lawrie, C. H., Araúzo-Bravo, M. J., Ribeiro, M. L., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1120 · Cited by 123
Yuan, X., Wu, H. K., Xu, H., Han, N., Chu, Q., Yu, S., Chen, Y., & Wu, K. (2015) · Scientific Reports · doi:10.1038/srep10338 · Cited by 122
MiR-200c downregulates HIF-1α and inhibits migration of lung cancer cells
Byun, Y., Choi, Y.-C., Jeong, Y., Lee, G., Yoon, S., Jeong, Y., Yoon, J., & Baek, K. (2019) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-019-0152-2 · Cited by 115
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
Dabral, S., Muecke, C., Valasarajan, C., Schmoranzer, M., Wietelmann, A., Semenza, G. L., Meister, M. A., Muley, T., Seeger‐Nukpezah, T., Samakovlis, C., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10044-z · Cited by 111
The evolving role of lymphatics in cancer metastasis
Farnsworth, R. H., Achen, M. G., & Stacker, S. A. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.04.008 · Cited by 100
Hypoxia-Dependent Angiogenesis and Lymphangiogenesis in Cancer
Schito, L. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-12734-3_5 · Cited by 100
Kurata, T., Oguri, T., Isobe, T., Ishioka, S., & Yamakido, M. (1999) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1999.tb00702.x · Cited by 99
Whitehurst, B. D., Flister, M. J., Bagaitkar, J., Volk, L. D., Bivens, C., Pickett, B., Castro‐Rivera, E., Brekken, R. A., Gerard, R. D., & Ran, S. (2007) · International Journal of Cancer · doi:10.1002/ijc.22937 · Cited by 97
Role of lymphatic vasculature in regional and distant metastases
Podgrabinska, S., & Skobe, M. (2014) · Microvascular Research · doi:10.1016/j.mvr.2014.07.004 · Cited by 93
Gulei, D., Magdo, L., Jurj, A. M., Ráduly, L., Cojocneanu, R., Moldovan, A. I., Moldovan, C. S., Florea, A., Paşca, S., Pop, L., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0102-8 · Cited by 89
Self-citationOverexpression of GLUT1 correlates with Kras mutations in lung carcinomas
Sasaki, H., Shitara, M., Yokota, K., Hikosaka, Y., Moriyama, S., Yano, M., & Fujii, Y. (2011) · Molecular Medicine Reports · doi:10.3892/mmr.2011.736 · Cited by 88
Hypoxia-induced autophagy as an additional mechanism in human osteosarcoma radioresistance
Feng, H., Wang, J., Chen, W., Shan, B., Guo, Y., Xu, J., Wang, L., Guo, P., & Zhang, Y. (2016) · Journal of bone oncology · doi:10.1016/j.jbo.2016.03.001 · Cited by 87
Teng, H., Yang, Y., Wei, H., Liu, Z., Liu, Z., Ma, Y., Gao, Z., Hou, L., & Zou, X. (2015) · Marine Drugs · doi:10.3390/md13063514 · Cited by 78
Zeng, Y., Opeskin, K., Goad, J. R., & Williams, E. D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1488 · Cited by 77
Kong, X., Zhao, Y., Li, X., Tao, Z., Hou, M., & Ma, H. (2019) · Cellular Physiology and Biochemistry · doi:10.33594/000000026 · Cited by 76
Currie, M. J., Hanrahan, V., Gunningham, S. P., Morrin, H. R., Frampton, C. M., Han, C., Robinson, B. A., & Fox, S. B. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.015644 · Cited by 71
Wu, C., Zhuang, Y., Jiang, S., Liu, S., Zhou, J., Wu, J., Teng, Y., Xia, B., Wang, R., & Zou, X. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3480 · Cited by 70
The Hypoxic Tumor Microenvironment: Driving the Tumorigenesis of Non-Small-Cell Lung Cancer
Foster, J. G., Wong, S. C. K., & Sharp, T. V. (2014) · Future Oncology · doi:10.2217/fon.14.201 · Cited by 68
Nanopharmacology in translational hematology and oncology
Berindan‐Neagoe, I., Braicu, C., Craciun, L., Irimie, A. I., & Takahashi, Y. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s60488 · Cited by 66
Self-citationChen, X., Wu, L., Li, D., Xu, Y., Zhang, L., Niu, K., Kong, R., Gu, J., Xu, Z., Chen, Z., et al. (2018) · Cancer Medicine · doi:10.1002/cam4.1527 · Cited by 66
NCRNA Combined Therapy as Future Treatment Option for Cancer
Braicu, C., Cătană, C.-S., Călin, G. A., & Berindan‐Neagoe, I. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140826153529 · Cited by 64
Self-citationHIF-1α and HIF-2α Differently Regulate the Radiation Sensitivity of NSCLC Cells
Roig, E. M., Groot, A. J., Yaromina, A., Hendrickx, T. C., Barbeau, L. M. O., Giuranno, L., Dams, G., Ient, J., Pimentel, V. O., van Gisbergen, M. W., et al. (2019) · Cells · doi:10.3390/cells8010045 · Cited by 63
Non‐coding RNAs as theranostics in human cancers
Redis, R. S., Berindan‐Neagoe, I., Pop, V. I., & Călin, G. A. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24038 · Cited by 62
Self-citationGarg, M. (2017) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2017.6 · Cited by 62
Braicu, C., Pileczki, V., Irimie, A., & Berindan‐Neagoe, I. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1688-5 · Cited by 61
Self-citationHypoxic regulation of the noncoding genome and NEAT1
Choudhry, H., & Mole, D. R. (2015) · Briefings in Functional Genomics · doi:10.1093/bfgp/elv050 · Cited by 61
SOX9 is an atypical intestinal tumor suppressor controlling the oncogenic Wnt/ß-catenin signaling
Prévostel, C., Rammah-Bouazza, C., Trauchessec, H., Canterel-Thouennon, L., Busson, M., Ychou, M., & Blache, P. (2016) · Oncotarget · doi:10.18632/oncotarget.10573 · Cited by 60
MicroRNA‐31‐5p enhances the Warburg effect via targeting FIH
Zhu, B., Cao, X., Zhang, W., Pan, G., Yi, Q., Zhong, W., & Yan, D. (2018) · The FASEB Journal · doi:10.1096/fj.201800803r · Cited by 60
Cheng, C., Chen, P., Hsieh, Y., Weng, C.-C., Chang, C., Yao, C., Hu, L., Wu, P., & Shen, C. (2015) · Oncotarget · doi:10.18632/oncotarget.5826 · Cited by 58
Upregulation of Wnt signaling under hypoxia promotes lung cancer progression
Hong, C.-F., Chen, W.-Y., & Wu, C. (2017) · Oncology Reports · doi:10.3892/or.2017.5807 · Cited by 56
Prognosis value of HIF-1α expression in patients with non-small cell lung cancer
Wang, Q., Hu, D.-F., Rui, Y., Jiang, A., Liu, Z., & Huang, L. (2014) · Gene · doi:10.1016/j.gene.2014.03.025 · Cited by 55
Hypoxic Modulation of Ca2+ Signaling in Human Venous Endothelial Cells
Aley, P. K., Porter, K. E., Boyle, J. P., Kemp, P. J., & Peers, C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413674200 · Cited by 55
Irigoyen, M., Ansó, E., Martínez, E., Garayoa, M., Martínez-Irujo, J. J., & Rouzaut, A. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.03.001 · Cited by 54
Okada, K., Osaki, M., Araki, K., Ishiguro, K., Ito, H., & Ohgi, S. (2005) · PubMed · Cited by 53
Agrimi, G., Brambilla, L., Frascotti, G., Pisano, I., Porro, D., Vai, M., & Palmieri, L. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.01703-10 · Cited by 52
Guo, Y., Zhang, M., Wang, F., Pei, G., Sun, F., Zhang, Y., He, X., Wang, Y., Song, J., Zhu, F., et al. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.04.007 · Cited by 48
Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery
Aldea, M. D., Craciun, L., Tomuleasa, C., Berindan‐Neagoe, I., Kacsó, G., Florian, I. Ş., & Crivii, C. B. (2014) · Tumor Biology · doi:10.1007/s13277-014-1676-8 · Cited by 44
Self-citationHIF-2α not HIF-1α overexpression confers poor prognosis in non–small cell lung cancer
Gao, Z., Wang, Y., Yuan, W.-D., Yuan, J.-Q., & Yuan, K. (2017) · Tumor Biology · doi:10.1177/1010428317709637 · Cited by 42
He, P., Qiu, K., & Jia, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-32737-z · Cited by 40
Twist may be associated with invasion and metastasis of hypoxic NSCLC cells
Wei, L., Sun, J., Cui, Y., Jiang, S.-L., Wang, X.-W., Lv, L., Xie, L., & Song, X. (2016) · Tumor Biology · doi:10.1007/s13277-016-4896-2 · Cited by 39
Ranasinghe, W. K. B., Sengupta, S., Williams, S., Chang, M., Shulkes, A., Bolton, D. M., Baldwin, G. S., & Patel, O. (2014) · Cancer Medicine · doi:10.1002/cam4.189 · Cited by 37
MiR-182 promotes glucose metabolism by upregulating hypoxia-inducible factor 1α in NSCLC cells
Wang, M., Wang, W., Wang, J., & Zhang, J. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.06.035 · Cited by 36
Jin, X., Luan, H., Chai, H., Yan, L., Zhang, J., Wang, Q., & Cao, L. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4716 · Cited by 34
Zhu, L., Xue, F., Cui, Y., Liu, S., Li, G. L., Li, J., Guan, B., Zeng, H., Bian, W., Yang, C. H., et al. (2019) · BioFactors · doi:10.1002/biof.1500 · Cited by 34
Zhang, N. (2010) · Biologics · doi:10.2147/btt.s11021 · Cited by 27
Takasaki, C., Kobayashi, M., Ishibashi, H., Akashi, T., & Okubo, K. (2016) · Molecular and Clinical Oncology · doi:10.3892/mco.2016.937 · Cited by 27
Hyperglycemia Promotes K-Ras-Induced Lung Tumorigenesis through BASCs Amplification
Micucci, C., Orciari, S., & Catalano, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105550 · Cited by 24
Ma, Y., Xiu, Z., Zhou, Z., Huang, B., Liu, J., Wu, X., Li, S., & Tang, X. (2019) · Journal of Cancer · doi:10.7150/jca.29933 · Cited by 24
Liu, X., Huang, Y., Jin, C., Zhou, Y., Chen, X., Li, J., Chen, Y., Li, M., Yao, Q., Li, K., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21537 · Cited by 20
MicroRNA‑214 upregulates HIF‑1α and VEGF by targeting ING4 in lung cancer cells
Li, Y., Zhao, L., Qi, Y., & Yang, X. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10170 · Cited by 20
Differential effect of hypoxia and acidity on lung cancer cell and fibroblast metabolism
Giatromanolaki, A. N., Liousia, M., Arelaki, S., Kalamida, D., Pouliliou, S., Mitrakas, A. G., Tsolou, A., Sivridis, E., & Koukourakis, M. I. (2017) · Biochemistry and Cell Biology · doi:10.1139/bcb-2016-0197 · Cited by 16
Wu, C., Zhuang, Y., Zhou, J., Liu, S., Zou, X., Wu, J., Wang, R., & Shu, P. (2019) · Biological Chemistry · doi:10.1515/hsz-2018-0351 · Cited by 14
Cited by
Hypoxia signaling in human health and diseases: implications and prospects for therapeutics
Luo, Z., Tian, M., Yang, G., Tan, Q., Chen, Y., Li, G., Zhang, Q., Li, Y., Wan, P., & Wu, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01080-1 · Cited by 499
Mesenchymal stem cells: Amazing remedies for bone and cartilage defects
Kangari, P., Talaei-Khozani, T., Razeghian-Jahromi, I., & Razmkhah, M. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-02001-1 · Cited by 286
Emerging role of tumor cell plasticity in modifying therapeutic response
Qin, S., Jiang, J., Lu, Y., Nice, E. C., Huang, C., Zhang, J., & He, W. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00313-5 · Cited by 268
Tumor cell plasticity in targeted therapy-induced resistance: Mechanisms and new strategies
Shi, Z.-D., Pang, K., Wu, Z.-X., Dong, Y., Hao, L., Qin, J.-X., Wang, W., Chen, Z.-S., & Han, C.-H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01383-x · Cited by 256
Metadata
- Authors
- Tirpe, A. A., Gulei, D., Ciortea, S. M., Crivii, C., & Berindan-Neagoe, I.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-12-05
- Volume
- 20
- Issue
- 24
- Pages
- 6140
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2992297284
- Cited by
- 438
- References
- 136
- FWCI
- 14.03
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.